Work

CYP2D6 genotype and adverse events to risperidone in children and adolescents

Year: 2019

Type: article

Study design: Observational Study

Source: Pediatric Research

DOI: 10.1038/s41390-019-0305-z

Authors: Kazeem A. Oshikoya, Katelyn M. Neely, Robert J. Carroll, Ida T. Aka, Angela C. Maxwell-Horn, Dan M. Roden, Sara L. Van Driest

Institutions: Vanderbilt University, Vanderbilt University Medical Center

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Vanderbilt University, Vanderbilt University Medical Center, Georgia Clinical and Translational Science Alliance, National Institutes of Health, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G1182793083, The Vanderbilt Institute for Clinical and Translational Research (VICTR), G2209161966, G4425699080, Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at Vanderbilt University, G5679716143, The Vanderbilt Institute for Clinical and Translational Research (VICTR), G9000025860, G9000033427, Clinical Pharmacology Training Program

OpenAlex ID: W2910160536

FWCI: 3.683

Cites: 34

Cited by: 29

Related to: 10